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Abstract:
Hypoxic Ischaemic Encephalopathy (HIE) may lead to death or severe long-term morbidity. 
Therapeutic Hypothermia (TH) increases survival without impairments in childhood, but prognostic 
uncertainty may remain for years after birth. Clear and accurate communication is imperative but 
challenging. This article explores the predictive value of routinely performed assessments during 
TH, as well as the qualitative research relating to parental experience. This article will benefit the 
paediatric trainees, consultants and nurse practitioners, in providing 1) the background information 
needed for initiating a conversation with parents regarding outcome and 2) optimising their 
communication with parents in translating jargon, prognosis and uncertainty.
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Main text:
Neonatal Hypoxic Ischaemic Encephalopathy (HIE) is a potentially devastating condition, which 
may progress to moderate to severe short-term morbidity, long-term disabilities or death.[1-5] 
Controlled reduction of an encephalopathic infant’s core temperature, known as Therapeutic 
hypothermia (TH), increases survival without impairment in childhood. TH is the standard care in 
developed countries.[1-2]
TH is indicated in newborn infants with evidence of perinatal asphyxia resulting in moderate to 
severe encephalopathy. Grade of encephalopathy is determined clinically (based on Sarnat score) 
and/or with amplitude-integrated electroencephalography (aEEG; moderate or severely abnormal 
pattern), Criterion for perinatal asphyxia typically includes meeting any one of: [1, 4-5]
 Acidosis on blood sample from cord or within 1 hour of age: pH<7.0 or base excess ≤-
16mmol/L
 Apgar score ≤ 5 at 10 minutes  
 Need for resuscitation at 10 minutes after birth (Such as endotracheal or mask ventilation ) 
During TH, core temperature is reduced to 33-34°C for 72 hours, using a servo-controlled (automatic 
feedback) cooling wrap, mattress or cap.  Infants require intensive care support and monitoring and 
are therefore frequently transferred to a tertiary neonatal intensive care unit, away from their parents. 
Clear and accurate communication is imperative in order to minimise parental distress, but this can 
be difficult. Clear and effective communication can be achieved if: 
1) Clinicians are aware of the accuracy of the prognostic tests they have performed, together 
with the level of uncertainty that exists 
2) Clinicians have an appreciation of the turbulent parental experience and are able to filter the 
frequency, volume and detail of their communications to meet the needs of the parents in a 
step-wise fashion.
3) Clinicians are able to translate medical terms relating to the current condition of the baby, 
and the future implications of this, into plain/simple language. 
This paper will explore each of these three points in turn. Firstly, by considering what prognostic 
information is available, and what weighting a clinician should place on this when considering 
certainty of outcome. 
1) DETERMINING PROGNOSIS & UNCERTAINTY 
Determining prognosis for an infant undergoing TH is a challenge for the attending clinician for 
many reasons:
 The initial working diagnosis of HIE may be incorrect (eg; encephalopathy due to sepsis, or 
metabolic conditions) and could be associated with other comorbidities (eg: cardiac or 
surgical problems)
 Pharmacological sedation may limit assessment
 No test is 100% predictive of infant outcome
 TH modifies the prognostic value of clinical and aEEG assessment[6]
 The prognostic value of many predictive markers may not be apparent until several days into 
the evolution of the infant’s abnormal neurological state 
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 Clinical trials report the composite outcome of ‘death and major neurodisability’, whereas 
clinicians must pragmatically try to separate these two entities[1, 4-5]
 Clinical trials and observational studies of cooled infants divide outcome into severe (death 
or disability) versus non-severe (survival without disability). Disability is often defined as the 
developmental scores being 1-2 standard deviations below the population mean, whereas a 
spectrum of neuromotor, cognitive and behavioural impairment may present through 
childhood[2-3, 7]
Death
Death following HIE is the most imminent outcome to prognosticate as this has immediate 
ramifications for both clinicians and parents. Accurate prognostication of death helps to 1) avoid 
futile but potentially distressing medical interventions, 2) offer appropriate palliative care with 
amelioration of pain and distress in the infant and 3) prepare parents for palliative care and / or death 
as much as possible (including attention to wider family, social support and cultural or religious 
requirements).
Death may occur due to global multi-organ injury, or following re-orientation of care due to severe 
brain injury. The ability to determine which infants are at highest risk of severe brain injury, in order 
to consider re-orientation of care, is, however, limited. Likewise, clinical trials are limited in their 
ability to provide prognostic markers of death of any cause. Nearly 75% of deaths reported in the TH 
clinical trials are following withdrawal or withholding of life-sustaining treatment, and are thus 
subject to bias.[1] This is reflected by the variable death rates in the contemporary cohorts of TH 
(6% - 23%). [8-11] 
Clinicians should be alert to:
 Imminent or inevitable death in infants with severe encephalopathy and multi-organ failure 
who are deteriorating despite maximal intensive care support.
 Infants in whom TH is futile and death highly likely. These infants may only be identified 
with time, as sequential evidence of a severe hypoxic-ischaemic insult and absence of 
neurological recovery is required: [12]
o Severe asphyxia: Apgar score < 3 at 10 min, and/or need for adrenaline during 
resuscitation, and/or an umbilical cord or first newborn blood gas pH<6.8 [12]
o Initial severe encephalopathy: Abnormal aEEG background (continuous low voltage 
or flat trace) at 6-12 hours after birth [12]
o Persistent abnormal aEEG background pattern at 24 hours of TH without 
improvement [12]
o Early brain lesions on Magnetic Resonance (MR) Imaging: Presence of basal-
ganglia/thalami predominant lesions at 48-72 hours of TH[13]
In all decisions relating to end-of-life care, the burden of treatment must be considered (e.g. are 
medical interventions causing non-ameliorable harm or discomfort without reciprocate benefit). In 
addition, clinicians must carefully examine their primary diagnosis of HIE to ensure potential 
reversible causes are not missed.
Disability
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Neurodevelopmental disabilities in survivors include cerebral palsy, developmental delay or 
intellectual impairment, blindness, and deafness (definitions and incidences of neurodisability are 
provided in Table 1).[1, 14]
Table 1 
Outcome Measure Percentage of 
Infants
Major Neurodisability at 18 to 24 months in survivors 29-32%
Infants with moderate encephalopathy at baseline 20-27%
Infants with severe encephalopathy at baseline 37-71%
Infants with moderately abnormal aEEG at baseline 12%
Infants with severely abnormal aEEG at baseline 58%
Component outcomes within ‘Major Neurodisability’ (Definitions are provided in brackets)
Neuromotor delay in survivors
(Bayley Scales of Infant Development – PDI >2 SD below mean)
26%
Developmental delay in survivors
(Bayley Scales of Infant Development – MDI >2 SD below mean)
25%
Cerebral palsy in survivors
(Range of movement difficulties affecting posture and motor function and often associated with 
difficulties of vision, hearing, intellect, communication and feeding)
11-23%
Blindness in survivors
(Vision < 6/60 in both eyes)
6%
Deafness in survivors
(Sensorineural deafness requiring amplification)
4%
Other outcomes not included in ‘Major Neurodisability’
NG Feeds at Discharge 11%
Seizures/anticonvulsant treatment at follow-up 9- 12%
Table 1: 18 to 24 month neurodevelopmental outcomes for infants treated with therapeutic 
hypothermia for Hypoxic Ischaemic Encephalopathy: Data extracted from [1, 10, 11, 14]. aEEG: 
Amplitude Integrated Electroencephalography, PDI: Psychomotor Development Index, SD: Standard 
Deviation, MDI: Mental Development Index.
Prognostic markers
Published studies typically reference the predictive value of prognostic markers relative to the 
composite outcome of death and major neurodisability. Based on data from these studies, many 
routinely performed assessments may be used to help further stratify ongoing risk of mortality and 
long-term disability. TH reduces the positive predictive value of many of these assessments:
A) Early markers of newborn condition:
TH decreases ongoing brain injury following HIE. The predictive values of early markers of 
infant condition, such as the Apgar score, early blood pH and base excess, and admission 
Sarnat stage, are therefore reduced, with the exception of infants at the very extremes of poor 
condition.[6, 15-19]
B) Serial clinical neurological assessment using modified Sarnat staging:
Impairment of renal and liver function, and reduced core temperature during TH, prolong the 
effect of sedatives. The evolution of an infant’s encephalopathic state, reflected by their 
Sarnat stage, is therefore modified. In addition, intensive care procedures, such as tracheal 
intubation, present barriers to clinical neurological examination. Neurological examinations 
performed after rewarming, and at discharge, have a lower false positive rate for death and 
disability, when compared with examination prior to commencing, or during, TH.[4, 18-19]
Page 5 of 29
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
6
C) Amplitude Integrated Electroencephalography (aEEG):
aEEG provides clinicians with a continuous, objective measure of brain function. Time to 
normalisation of the background voltage pattern, as well as time to develop sleep-wake 
cycling, are currently the best predictors of survival without major neurodisability, during 
TH. Persistence of an abnormal aEEG background beyond 48 - 72 hours of age is highly 
predictive of later disability.[11, 20-21] 
D) Pattern of brain injury on Magnetic Resonance (MR)Imaging:
Identification of moderate to severe abnormalities of the basal ganglia, thalami, internal capsule or 
white matter, following expert interpretation of MR brain scans, holds a high predictive value of 
death or major disability.[13, 22-23] 
      E) Metabolite ratio and quantification on brain magnetic resonance spectroscopy:
Thalamic Lactate-N acetyl aspartate (NAA) ratio > 0.22 predicted death or disability with an 
accuracy of 90%. Although spectroscopy offers an objective measure of brain injury, it requires post 
processing and is currently not in routine clinical use. Neurodevelopmental abnormalities may still 
occur, however, in infants with no obvious, or only minor brain tissue, diffusion-weighted or 
spectroscopy MR abnormalities.[13, 22-24] 
Figure 1 provides a chronological reference of predictive values of death and major disability, 
before, during and after TH. Accurate neurological examination and aEEG pattern interpretation are 
essential for achieving the stated prognostic values. Adequate training is essential for trainees to 
achieve competence in these skills. Normalisation of aEEG within 48hours of cooling, mild or no 
encephalopathy after rewarming or at discharge and a normal brain MR imaging increase the 
chances of a good prognosis. 
[Figure 1.] 
Prognostic certainty therefore increases with time, as more clinical, neurophysiological (aEEG), and 
neuroimaging information becomes available. Nevertheless, a degree of uncertainty will persist; 
clinicians should be open with parents regarding uncertainty. The degree of uncertainty portrayed is 
a fine balance; over- or understating uncertainty may unfairly give parents an unrealistic perception 
of their child’s risk of long-term impairment (see figure 2). Parents should be aware that no test or 
assessment is 100% predictive for death or severe disability.  
[Figure 2.]
Later Childhood Outcomes
Follow-up data from TH trials, in children aged 6 to 7 years, are supportive that the neuroprotective benefits 
of TH continue into school-age. Benefits extend to both motor and cognitive domains, with increased 
survival with intelligence quotient ≥85, reduced rates of cerebral palsy and better gross motor function and 
manual ability scores.[2-3, 7]  School-age outcomes for infants who received TH are shown in table 2. 
Table 2
Outcomes at 6 to 7 years following TH Percentage of Infants
Survival[2, 3] 71-72%
Neurodisability in survivors[2, 3]: (Definitions are provided in brackets)*:
Severe disability 14-16%
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(IQ <55 (<3 SD), GMFCS 4 or 5 (needs adaptive seating or has severely limited mobility), or 
no useful vision)
Moderate disability
(IQ 55-69 (2-3 SD), GMFCS 2[2] or 3[2, 3] (minimal ability to perform gross motor skills or 
requires assistance with walking), moderately reduced vision[2], bilateral deafness[3], or 
epilepsy requiring anticonvulsant therapy[3])
8-19%
Mild disability
(IQ70-84 (1-2 SD), GMFCS 1[2, 3] or 2[3] (able to walk independently but may have some gait 
abnormalities), or abnormality in one or both eyes with normal or nearly normal vision[2])
10-25%
No disability
(IQ ≥85 (≥1 SD), with no cerebral palsy, hearing or visual deficits, or epilepsy)
41-68%
Specific neurological impairments in survivors[2, 3, 11]:
Cerebral Palsy 11-21%
Bilateral blindness 1-1.5%
Hearing impairment 4-5%
Seizures or confirmed epilepsy 10-13%
Cognitive Function in survivors[7]:
Mean IQ: 80.9 (Range: 39 to 121) ---
IQ ≥85 (>1 SD below the mean IQ) 48%
IQ≥70 (>2 SD below the mean IQ) 75%
Special Educational Needs in survivors[2, 7]:
Parental reported behavioural problems 7%
Mainstream school with academic or behavioural educational support 31%
Special educational needs school 14%
Table 2: Outcomes at 6 to 7 years in children who received therapeutic hypothermia. *Differences in 
trial definitions are individually referenced. IQ: Intelligence Quotient, GMFCS: Gross Motor 
Function Classification System, SD: Standard Deviation.
A spectrum of neuromotor and cognitive impairment may thus occur. Cognitive impairment may 
occur even in the absence of cerebral palsy. Predicting isolated cognitive impairment at birth is not 
possible, but infants with cognitive or language difficulties at 18-24 months are at highest risk and 
are a group likely to benefit from preschool identification and early, pro-active, educational 
intervention.[25]
2) PARENTAL COMMUNICATION CHALLENGES 
Parents experience uncertainty that may persist years into their child’s development.[26-27] The 
combined use of unexplained jargon and medical acronyms, as well as potentially contradictory 
statements by medical personnel risks augmenting parental confusion and their distress.[26] 
Understanding Parental Experience and Expectations
Clinicians must be sensitive to the extreme stress parents are placed under, following the delivery 
and neonatal admission of an infant with suspected HIE. Parents are presented with an unexpected, 
rapidly emergent, adverse event that may threaten the life of their newborn child. Parents will have 
little control and little understanding, whilst the actions of the perinatal teams may appear 
chaotic.[26-27]
Information given in the early stages of an infant’s admission may be forgotten or misconstrued. 
Qualitative research identifies that parents often feel they are provided with infrequent and 
fragmented updates. Parents struggle to retain and organise information into logical thought 
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processes.[26] Conceptualising ongoing uncertainty is then very difficult to achieve and, critically, 
involvement in complex decision-making is compromised.[26-27] 
Optimal communication with parents
Clinicians may lessen the burden of communication in several ways. Parents benefit from frequent 
updates, use of plain English, and regular sign-posting to the next-step in their infant’s assessment 
and treatment. Summary discussions that review the infant’s progress from admission provide a vital 
opportunity to correct misunderstandings.[26-28] Communication to parents who cannot understand 
or speak the English language must include use of a qualified medical translator.
Parental-infant attachment is challenged due to early and prolonged separation. TH apparatus, 
ventilator tubing and monitoring present both physical and psychological barriers.[27-28] 
Opportunity to be involved in infant cares from an early stage, milk expression and normalisation of 
infant handling following rewarming may help.[27] 
Parents face ongoing uncertainty about their child’s future following neonatal discharge. This is a 
significant source of distress. A clear post-discharge follow-up plan should be offered.[27] 
Table 3 lists some of the key learning points that have been identified by qualitative research studies 
into parental experiences.
Table 3
1) Consistent & Frequent Communication:
Brief update by the neonatal team prior to transfer to the Neonatal Unit
Senior member of the neonatal team should update parents as soon as possible after admission
If the mother is unable to come to the neonatal unit, the neonatal team should go to the mother (or direct telephone call 
where in a different hospital) 
Medical updates should be provided at least daily or after any significant event
Ideally both parents, or alternatively an additional supporting family member, should be present for significant updates
Summary discussions should be provided to clarify parents’ total understanding of events
Obstetric debrief, before the mother’s discharge, will be beneficial for parental understanding of delivery events
2) Avoid Jargon & Acknowledge Prognostic Uncertainty:
Use simple lay language: explain jargon if used
 TH within guideline criteria is not experimental; parents should be reassured it is well-researched and ‘proven’
 Be honest regarding uncertainty; this is inevitable
 Share what prognostic information is known openly and honestly
 Ensure post-discharge follow-up is offered with sufficient time to address parental anxiety and questions
3) Address Barriers to Attachment:
 Parents should see, and by preference have physical contact with, baby prior to transport from delivery room
Maximise opportunities for parental physical contact and involvement (e.g. stationary holding of infant’s hand, 
scheduled cares/nappy changes, and feeding if started)
 Ensure pain is monitored and attended to; reassure parents of this
 Provision of parent room on unit or patient hotel, if distance from home is barrier to parental visiting
 Explain the function of monitoring equipment used in basic terms
 Ensure early parental orientation to hospital facilities and unit routines (including coffee room / vending machines / 
restaurant, ward round /hand-over times, visiting hours for extended family & parking)
Table 3: Key learning from qualitative studies investigating parental experiences following 
admission of an infant with Hypoxic Ischaemic Encephalopathy for Therapeutic Hypothermia 
(TH)[26-28]
3) TRANSLATING JARGON AND PUTTING IT ALL TOGETHER
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Medical jargon related to TH and HIE will be novel, daunting and difficult for parents to recall. Use 
of clear language is important for parental understanding, and this is the immediate priority. It is, 
however, inevitable that parents will read or overhear medical terms during the course of their 
infant’s neonatal admission. For this reason, key medical terminologies should be explained to 
parents once their baseline understanding has been established. Common medical terms relating to 
HIE, with examples of lay explanations that parents may find helpful, are provided in the online 
supplementary figure 1. 
Vague/ambiguous terms should be avoided, even in the presence of uncertainty. For example, 
‘Developmental Delay’ is commonly used, but can be interpreted in many ways and should be 
avoided unless further clarification is provided. Parents may infer that their child will eventually 
attain all their milestones whereas there may be significant risk that the infant’s ability to walk, see, 
hear, communicate and learn will be permanently impaired.     
 
Communication with parents should progress through several stages (Table 4). Each stage may need 
to be adapted if infant condition is critical, worsening, and ongoing treatment considered futile. 
Communication should be delivered in conjunction with multidisciplinary support, including the 
nursing team, family worker or perinatal psychologist.
Table 4
1. Immediate parental update (ideally in delivery room)
Address the infant by name if parents have chosen one for their baby. Explain that: 
a. Infant has been unwell and has required help/resuscitation at birth
b. Ongoing support if required (e.g. ventilation)
c. It is possible that the baby has had a period of reduced blood flow and oxygen to the whole body. 
This may lead to injury to the baby’s brain and other vital organs including the kidney, liver and 
heart.
d. It is too early to know how severely the baby has been affected
e. The infant will be admitted to the neonatal unit for further assessment and may need a treatment 
called ‘Cooling’ to protect the brain from ongoing injury
2. Parental update following admission and TH commenced (undertaken by both medical and nursing 
team member looking after the infant):
a. Ascertain parental understanding
b. Provide explanation of general condition of baby (including multi-organ support if relevant) and re-
iterate support they needed after birth (explain ventilation, chest compressions, medications)
c. Explain what HIE is (including risk of death or major disability)
d. Explain role and duration of TH & need for transfer to ‘cooling centre’ (if relevant)
e. Explain TH improves survival and reduces the number of babies with severe long-term disability
f. Explain prognosis is uncertain but that over the next week it will become clearer how severely the 
baby has been affected; as response to TH is observed and results of investigations are available
g. Reassure infant will be kept comfortable and monitored by experienced staff
h. When at cotside: briefly explain the role of monitoring leads connected to baby (Pulse-oximeter, 
ECG, aEEG)
i. Summarise discussion at end, clarify parental understanding, offer time for questions and sign-post 
when next update is expected and what further information may be known at that time
j. Ensure parents will be given tour of neonatal unit, and that visiting rules, parking and hospital 
facilities will be explained
3. Updates day 1 – 3 (in TH centre, preferably as a multidisciplinary team with nurses, family worker or 
psychologist):
a. Update at least daily:
i. Overall clinical condition (e.g. Lung/Heart/Kidney function)
ii. Level of encephalopathy & interpretation of aEEG if this aids with assessment of prognosis
iii. Seizure management, if required
iv. Explain timeline for rewarming and pre-warn of potential risk of further seizures and risk 
of extension of duration of TH
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v. Consider early discussion relating to limit of escalation of therapy if infant critically 
unwell, high risk of death or treatment considered futile
b. Ensure the junior medical team and nursing team caring for the family are in agreement with the 
information given to the family. Clear any misunderstandings within the team about prognosis to 
avoid parents being told confusing and variable information
4. Update day 4: rewarming (in TH centre):
a. Explain how baby has coped with re-warming and, following clinical assessment of the baby’s 
encephalopathy and aEEG, discuss what this may indicate for their prognosis
5. Subsequent updates: (May take place in TH centre or at local hospital)
a. When MRI brain scan is anticipated and when the result of this will be known
b. Pre-Discharge: 
i. Summarise neonatal admission including treatment that baby has received and results of 
investigations
ii. Update parents on what the results of the investigations may mean for the baby’s future 
development and needs
iii. Clarify the level of uncertainty that remains, sign-post follow-up plan and explain what 
support will be made available if the baby needs
Table 4: Stages of parental communication. TH: Therapeutic Hypothermia, HIE: Hypoxic Ischaemic 
Encephalopathy, ECG: Electrocardiogram, aEEG: amplitude-integrated electroencephalography.
See also parental communication flow chart: figure 3.
Further written parental guidance may be sought from the Bliss Patient Information Leaflet: “HIE 
(Hypoxic-ischaemic encephalopathy) information for parents”[29] 
Worked examples of using this paper to construct parental communication are provided in the online 
supplement 2. This may be used for personal reflection or for supervised group education.
[Figure 3.]
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Figure Legends:
Figure 1: Risk of Death or Major Disability (moderate to severe disability as defined in tables 1 & 
2): Routinely available prognostic markers from birth to discharge in infants treated with Therapeutic 
Hypothermia for Hypoxic Ischaemic Encephalopathy. Only markers with outcome data at >12-24 
months included. *Caution: small number of participants, †Combined hypo/normo-thermia group 
data, ‡Major MRI abnormality = Moderate/severe basal ganglia or thalamic lesions, severe white 
matter lesions, or an abnormal posterior limb of the internal capsule. PPV: Positive Predictive Value, 
NPV: Negative Predictive Value, aEEG: amplitude integrated Electroencephalogram, NG: 
Nasogastric, MRI: Magnetic Resonance Imaging. 
Figure 2: Schematic demonstrating the spectrum of prognostic uncertainty in Hypoxic Ischaemic 
Encephalopathy. Clinicians must balance the predictive value of prognostic markers with the level of 
reassurance/uncertainty reported to parents. 
Figure 3: Parental communication flow-chart. HIE: Hypoxic Ischaemic Encephalopathy, USS: 
Ultrasound Scan, aEEG: Amplitude Integrated Electroencephalogram, MR: Magnetic Resonance, 
EEG: Electroencephalogram. 
Page 14 of 29
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
Risk of Death or Major Disability: Infants Treated with Therapeutic Hypothermia
Clinical:
10 minute Apgar score 017: PPV 73%
Meets trial criteria for cooling1: PPV 46%
Grade of clinical encephalopathy by modified Sarnat staging - first 6 hours4:  
Ø Moderate encephalopathy: PPV 32%
Ø Severe encephalopathy: PPV 72%
aEEG classification prior to active cooling11: 
(Most severe trace sustained for 30 minutes in 1st 6 hours)
Ø Moderately abnormal voltage: PPV 26%
Ø Severely abnormal voltage: PPV 77%
aEEG:
Cranial Ultrasound at 24 – 72 hours: Resistance Index ≤0.5530: PPV 60% | NPV 78%
Clinical:
Sarnat & Sarnat Staging on Day 4 (Post-Warming)18:
Ø Severe (Grade 3) Encephalopathy: PPV 89%
Ø Moderate (Grade 2) Encephalopathy: PPV 31%
Ø Mild (Grade 1) Encephalopathy: PPV 29%
NICHD Clinical Encephalopathy Stage at Discharge†,19:
Ø Moderate/Severe Stage at Discharge: PPV 84%
Ø Mild/No Encephalopathy at Discharge: PPV 31%
Ø NG/Gastrostomy Fed at Discharge: PPV 84% | NPV 76%
Ø Hypertonia at Discharge: PPV 69% | NPV 73%
Ø Fisted hand at Discharge: PPV 72% | NPV 68%
Ø Gag reflex absent at Discharge: PPV 76% | NPV 75%
MRI (at 1 to 4 weeks of age):
Major MRI abnormality‡,23: PPV 76% | NPV 91%
Normal MRI22: PPV 91% | NPV 56% for Survival/IQ>70 by 6-7 years
Ø Survivors with normal MRI: 50% No Disability or IQ≥85 | 34% Mild Disability or IQ70-84
16% Moderate Disability or IQ55-69 | 0%* Severe Disability or IQ<55
Age at 
assessment
Moderately or severely abnormal 
aEEG trace by voltage criteria20: Sleep-Wake Cycling not achieved
21:
PPV NPV PPV NPV
24 hours 62% 96% 53% 100%*
36 hours 78% 96% 63% 100%*
48 hours 91% 92% 65% 100%*
72 hours 96% 87% 82% 33%
>72 Hours (Post-Warming)
First 6 Hours
Cooling Phase
: NPV 100%* (i.e Normal voltage, no electrical seizures)
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Parental Communication in Hypoxic Ischaemic Encephalopathy
Suspected Hypoxic Ischaemic Encephalopathy 
Immediate Parental Update – Delivery Suite
Show infant to parents 
Encourage skin contact where possible 
- However brief -
Admit, Clarify Diagnosis & Decision to Cool
Stratify Prognosis - (See FIGURE 1)
- Grade & Evolution of Encephalopathy
- Multi-Organ Involvement/ Intensive 
Support
- Cranial USS
- aEEG Interpretation: Background / 
Sleep-Wake Cycling
- MR Brain Scan
Current condition of infant
Concerns relating to HIE & plans regarding cooling 
Be open regarding prognostic uncertainty early on
Frequent Further Updates
- Brief: At Baby’s Cotside
- If significant bad news: Quiet Room 
- Both parents present where possible
- What is known / What is still uncertain
- When more information is expected
- If cooling outside criteria – make this 
clear
Discharge
- Ensure parents have clear understanding of events since birth, treatment given & 
results of relevant investigations
- If reports are awaited (e.g. EEG / MR) ensure parents are told when they can expect to 
know the results and when the infant will next be seen in outpatients
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